Similarly, a study by Jung-Hynes and Ahmad (4) demonstrated that Sirt1 overexpression occurs in both PC3 cells (which lack p53) and PC3-p53 cells (with wild-type p53), regardless of p53 in prostate cancer cells. The gene discussed is TP53; the disease is prostate carcinoma.